1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Major Depressive Disorder (MDD) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Antidepressant Drugs 1.2.3 SSRIs 1.2.4 SNRIs 1.2.5 Benzodiazepines 1.2.6 Others 1.3 Market by Application 1.3.1 Global Major Depressive Disorder (MDD) Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Major Depressive Disorder (MDD) Market Perspective (2016-2027) 2.2 Major Depressive Disorder (MDD) Growth Trends by Regions 2.2.1 Major Depressive Disorder (MDD) Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Major Depressive Disorder (MDD) Historic Market Share by Regions (2016-2021) 2.2.3 Major Depressive Disorder (MDD) Forecasted Market Size by Regions (2022-2027) 2.3 Major Depressive Disorder (MDD) Industry Dynamic 2.3.1 Major Depressive Disorder (MDD) Market Trends 2.3.2 Major Depressive Disorder (MDD) Market Drivers 2.3.3 Major Depressive Disorder (MDD) Market Challenges 2.3.4 Major Depressive Disorder (MDD) Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Major Depressive Disorder (MDD) Players by Revenue 3.1.1 Global Top Major Depressive Disorder (MDD) Players by Revenue (2016-2021) 3.1.2 Global Major Depressive Disorder (MDD) Revenue Market Share by Players (2016-2021) 3.2 Global Major Depressive Disorder (MDD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Major Depressive Disorder (MDD) Revenue 3.4 Global Major Depressive Disorder (MDD) Market Concentration Ratio 3.4.1 Global Major Depressive Disorder (MDD) Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Major Depressive Disorder (MDD) Revenue in 2020 3.5 Major Depressive Disorder (MDD) Key Players Head office and Area Served 3.6 Key Players Major Depressive Disorder (MDD) Product Solution and Service 3.7 Date of Enter into Major Depressive Disorder (MDD) Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Major Depressive Disorder (MDD) Breakdown Data by Type 4.1 Global Major Depressive Disorder (MDD) Historic Market Size by Type (2016-2021) 4.2 Global Major Depressive Disorder (MDD) Forecasted Market Size by Type (2022-2027) 5 Major Depressive Disorder (MDD) Breakdown Data by Application 5.1 Global Major Depressive Disorder (MDD) Historic Market Size by Application (2016-2021) 5.2 Global Major Depressive Disorder (MDD) Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Major Depressive Disorder (MDD) Market Size (2016-2027) 6.2 North America Major Depressive Disorder (MDD) Market Size by Type 6.2.1 North America Major Depressive Disorder (MDD) Market Size by Type (2016-2021) 6.2.2 North America Major Depressive Disorder (MDD) Market Size by Type (2022-2027) 6.2.3 North America Major Depressive Disorder (MDD) Market Size by Type (2016-2027) 6.3 North America Major Depressive Disorder (MDD) Market Size by Application 6.3.1 North America Major Depressive Disorder (MDD) Market Size by Application (2016-2021) 6.3.2 North America Major Depressive Disorder (MDD) Market Size by Application (2022-2027) 6.3.3 North America Major Depressive Disorder (MDD) Market Size by Application (2016-2027) 6.4 North America Major Depressive Disorder (MDD) Market Size by Country 6.4.1 North America Major Depressive Disorder (MDD) Market Size by Country (2016-2021) 6.4.2 North America Major Depressive Disorder (MDD) Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe Major Depressive Disorder (MDD) Market Size (2016-2027) 7.2 Europe Major Depressive Disorder (MDD) Market Size by Type 7.2.1 Europe Major Depressive Disorder (MDD) Market Size by Type (2016-2021) 7.2.2 Europe Major Depressive Disorder (MDD) Market Size by Type (2022-2027) 7.2.3 Europe Major Depressive Disorder (MDD) Market Size by Type (2016-2027) 7.3 Europe Major Depressive Disorder (MDD) Market Size by Application 7.3.1 Europe Major Depressive Disorder (MDD) Market Size by Application (2016-2021) 7.3.2 Europe Major Depressive Disorder (MDD) Market Size by Application (2022-2027) 7.3.3 Europe Major Depressive Disorder (MDD) Market Size by Application (2016-2027) 7.4 Europe Major Depressive Disorder (MDD) Market Size by Country 7.4.1 Europe Major Depressive Disorder (MDD) Market Size by Country (2016-2021) 7.4.2 Europe Major Depressive Disorder (MDD) Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Major Depressive Disorder (MDD) Market Size (2016-2027) 8.2 Asia-Pacific Major Depressive Disorder (MDD) Market Size by Type 8.2.1 Asia-Pacific Major Depressive Disorder (MDD) Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Major Depressive Disorder (MDD) Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Major Depressive Disorder (MDD) Market Size by Type (2016-2027) 8.3 Asia-Pacific Major Depressive Disorder (MDD) Market Size by Application 8.3.1 Asia-Pacific Major Depressive Disorder (MDD) Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Major Depressive Disorder (MDD) Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Major Depressive Disorder (MDD) Market Size by Application (2016-2027) 8.4 Asia-Pacific Major Depressive Disorder (MDD) Market Size by Region 8.4.1 Asia-Pacific Major Depressive Disorder (MDD) Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Major Depressive Disorder (MDD) Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Major Depressive Disorder (MDD) Market Size (2016-2027) 9.2 Latin America Major Depressive Disorder (MDD) Market Size by Type 9.2.1 Latin America Major Depressive Disorder (MDD) Market Size by Type (2016-2021) 9.2.2 Latin America Major Depressive Disorder (MDD) Market Size by Type (2022-2027) 9.2.3 Latin America Major Depressive Disorder (MDD) Market Size by Type (2016-2027) 9.3 Latin America Major Depressive Disorder (MDD) Market Size by Application 9.3.1 Latin America Major Depressive Disorder (MDD) Market Size by Application (2016-2021) 9.3.2 Latin America Major Depressive Disorder (MDD) Market Size by Application (2022-2027) 9.3.3 Latin America Major Depressive Disorder (MDD) Market Size by Application (2016-2027) 9.4 Latin America Major Depressive Disorder (MDD) Market Size by Country 9.4.1 Latin America Major Depressive Disorder (MDD) Market Size by Country (2016-2021) 9.4.2 Latin America Major Depressive Disorder (MDD) Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Major Depressive Disorder (MDD) Market Size (2016-2027) 10.2 Middle East & Africa Major Depressive Disorder (MDD) Market Size by Type 10.2.1 Middle East & Africa Major Depressive Disorder (MDD) Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Major Depressive Disorder (MDD) Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Major Depressive Disorder (MDD) Market Size by Type (2016-2027) 10.3 Middle East & Africa Major Depressive Disorder (MDD) Market Size by Application 10.3.1 Middle East & Africa Major Depressive Disorder (MDD) Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Major Depressive Disorder (MDD) Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Major Depressive Disorder (MDD) Market Size by Application (2016-2027) 10.4 Middle East & Africa Major Depressive Disorder (MDD) Market Size by Country 10.4.1 Middle East & Africa Major Depressive Disorder (MDD) Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Major Depressive Disorder (MDD) Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Pfizer 11.1.1 Pfizer Company Details 11.1.2 Pfizer Business Overview 11.1.3 Pfizer Major Depressive Disorder (MDD) Introduction 11.1.4 Pfizer Revenue in Major Depressive Disorder (MDD) Business (2016-2021) 11.1.5 Pfizer Recent Development 11.2 GlaxoSmithKline 11.2.1 GlaxoSmithKline Company Details 11.2.2 GlaxoSmithKline Business Overview 11.2.3 GlaxoSmithKline Major Depressive Disorder (MDD) Introduction 11.2.4 GlaxoSmithKline Revenue in Major Depressive Disorder (MDD) Business (2016-2021) 11.2.5 GlaxoSmithKline Recent Development 11.3 Merck 11.3.1 Merck Company Details 11.3.2 Merck Business Overview 11.3.3 Merck Major Depressive Disorder (MDD) Introduction 11.3.4 Merck Revenue in Major Depressive Disorder (MDD) Business (2016-2021) 11.3.5 Merck Recent Development 11.4 AstraZeneca 11.4.1 AstraZeneca Company Details 11.4.2 AstraZeneca Business Overview 11.4.3 AstraZeneca Major Depressive Disorder (MDD) Introduction 11.4.4 AstraZeneca Revenue in Major Depressive Disorder (MDD) Business (2016-2021) 11.4.5 AstraZeneca Recent Development 11.5 Eli Lily 11.5.1 Eli Lily Company Details 11.5.2 Eli Lily Business Overview 11.5.3 Eli Lily Major Depressive Disorder (MDD) Introduction 11.5.4 Eli Lily Revenue in Major Depressive Disorder (MDD) Business (2016-2021) 11.5.5 Eli Lily Recent Development 11.6 Johnson & Johnson 11.6.1 Johnson & Johnson Company Details 11.6.2 Johnson & Johnson Business Overview 11.6.3 Johnson & Johnson Major Depressive Disorder (MDD) Introduction 11.6.4 Johnson & Johnson Revenue in Major Depressive Disorder (MDD) Business (2016-2021) 11.6.5 Johnson & Johnson Recent Development 11.7 Forest Laboratories 11.7.1 Forest Laboratories Company Details 11.7.2 Forest Laboratories Business Overview 11.7.3 Forest Laboratories Major Depressive Disorder (MDD) Introduction 11.7.4 Forest Laboratories Revenue in Major Depressive Disorder (MDD) Business (2016-2021) 11.7.5 Forest Laboratories Recent Development 11.8 Sanofi-Aventis 11.8.1 Sanofi-Aventis Company Details 11.8.2 Sanofi-Aventis Business Overview 11.8.3 Sanofi-Aventis Major Depressive Disorder (MDD) Introduction 11.8.4 Sanofi-Aventis Revenue in Major Depressive Disorder (MDD) Business (2016-2021) 11.8.5 Sanofi-Aventis Recent Development 11.9 H. Lundbeck 11.9.1 H. Lundbeck Company Details 11.9.2 H. Lundbeck Business Overview 11.9.3 H. Lundbeck Major Depressive Disorder (MDD) Introduction 11.9.4 H. Lundbeck Revenue in Major Depressive Disorder (MDD) Business (2016-2021) 11.9.5 H. Lundbeck Recent Development 11.10 Bristol-Myers Squibb 11.10.1 Bristol-Myers Squibb Company Details 11.10.2 Bristol-Myers Squibb Business Overview 11.10.3 Bristol-Myers Squibb Major Depressive Disorder (MDD) Introduction 11.10.4 Bristol-Myers Squibb Revenue in Major Depressive Disorder (MDD) Business (2016-2021) 11.10.5 Bristol-Myers Squibb Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Major Depressive Disorder (MDD) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Antidepressant Drugs Table 3. Key Players of SSRIs Table 4. Key Players of SNRIs Table 5. Key Players of Benzodiazepines Table 6. Key Players of Others Table 7. Global Major Depressive Disorder (MDD) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Major Depressive Disorder (MDD) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Major Depressive Disorder (MDD) Market Size by Regions (2016-2021) & (US$ Million) Table 10. Global Major Depressive Disorder (MDD) Market Share by Regions (2016-2021) Table 11. Global Major Depressive Disorder (MDD) Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 12. Global Major Depressive Disorder (MDD) Market Share by Regions (2022-2027) Table 13. Major Depressive Disorder (MDD) Market Trends Table 14. Major Depressive Disorder (MDD) Market Drivers Table 15. Major Depressive Disorder (MDD) Market Challenges Table 16. Major Depressive Disorder (MDD) Market Restraints Table 17. Global Major Depressive Disorder (MDD) Revenue by Players (2016-2021) & (US$ Million) Table 18. Global Major Depressive Disorder (MDD) Market Share by Players (2016-2021) Table 19. Global Top Major Depressive Disorder (MDD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Major Depressive Disorder (MDD) as of 2020) Table 20. Ranking of Global Top Major Depressive Disorder (MDD) Companies by Revenue (US$ Million) in 2020 Table 21. Global 5 Largest Players Market Share by Major Depressive Disorder (MDD) Revenue (CR5 and HHI) & (2016-2021) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Major Depressive Disorder (MDD) Product Solution and Service Table 24. Date of Enter into Major Depressive Disorder (MDD) Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Major Depressive Disorder (MDD) Market Size by Type (2016-2021) (US$ Million) Table 27. Global Major Depressive Disorder (MDD) Revenue Market Share by Type (2016-2021) Table 28. Global Major Depressive Disorder (MDD) Forecasted Market Size by Type (2022-2027) (US$ Million) Table 29. Global Major Depressive Disorder (MDD) Revenue Market Share by Type (2022-2027) & (US$ Million) Table 30. Global Major Depressive Disorder (MDD) Market Size Share by Application (2016-2021) & (US$ Million) Table 31. Global Major Depressive Disorder (MDD) Revenue Market Share by Application (2016-2021) Table 32. Global Major Depressive Disorder (MDD) Forecasted Market Size by Application (2022-2027) (US$ Million) Table 33. Global Major Depressive Disorder (MDD) Revenue Market Share by Application (2022-2027) & (US$ Million) Table 34. North America Major Depressive Disorder (MDD) Market Size by Type (2016-2021) (US$ Million) Table 35. North America Major Depressive Disorder (MDD) Market Size by Type (2022-2027) & (US$ Million) Table 36. North America Major Depressive Disorder (MDD) Market Size by Application (2016-2021) (US$ Million) Table 37. North America Major Depressive Disorder (MDD) Market Size by Application (2022-2027) & (US$ Million) Table 38. North America Major Depressive Disorder (MDD) Market Size by Country (2016-2021) & (US$ Million) Table 39. North America Major Depressive Disorder (MDD) Market Size by Country (2022-2027) & (US$ Million) Table 40. Europe Major Depressive Disorder (MDD) Market Size by Type (2016-2021) (US$ Million) Table 41. Europe Major Depressive Disorder (MDD) Market Size by Type (2022-2027) & (US$ Million) Table 42. Europe Major Depressive Disorder (MDD) Market Size by Application (2016-2021) (US$ Million) Table 43. Europe Major Depressive Disorder (MDD) Market Size by Application (2022-2027) & (US$ Million) Table 44. Europe Major Depressive Disorder (MDD) Market Size by Country (2016-2021) & (US$ Million) Table 45. Europe Major Depressive Disorder (MDD) Market Size by Country (2022-2027) & (US$ Million) Table 46. Asia-Pacific Major Depressive Disorder (MDD) Market Size by Type (2016-2021) (US$ Million) Table 47. Asia-Pacific Major Depressive Disorder (MDD) Market Size by Type (2022-2027) & (US$ Million) Table 48. Asia-Pacific Major Depressive Disorder (MDD) Market Size by Application (2016-2021) (US$ Million) Table 49. Asia-Pacific Major Depressive Disorder (MDD) Market Size by Application (2022-2027) & (US$ Million) Table 50. Asia-Pacific Major Depressive Disorder (MDD) Market Size by Region (2016-2021) & (US$ Million) Table 51. Asia-Pacific Major Depressive Disorder (MDD) Market Size by Region (2022-2027) & (US$ Million) Table 52. Latin America Major Depressive Disorder (MDD) Market Size by Type (2016-2021) (US$ Million) Table 53. Latin America Major Depressive Disorder (MDD) Market Size by Type (2022-2027) & (US$ Million) Table 54. Latin America Major Depressive Disorder (MDD) Market Size by Application (2016-2021) (US$ Million) Table 55. Latin America Major Depressive Disorder (MDD) Market Size by Application (2022-2027) & (US$ Million) Table 56. Latin America Major Depressive Disorder (MDD) Market Size by Country (2016-2021) & (US$ Million) Table 57. Latin America Major Depressive Disorder (MDD) Market Size by Country (2022-2027) & (US$ Million) Table 58. Middle East & Africa Major Depressive Disorder (MDD) Market Size by Type (2016-2021) (US$ Million) Table 59. Middle East & Africa Major Depressive Disorder (MDD) Market Size by Type (2022-2027) & (US$ Million) Table 60. Middle East & Africa Major Depressive Disorder (MDD) Market Size by Application (2016-2021) (US$ Million) Table 61. Middle East & Africa Major Depressive Disorder (MDD) Market Size by Application (2022-2027) & (US$ Million) Table 62. Middle East & Africa Major Depressive Disorder (MDD) Market Size by Country (2016-2021) & (US$ Million) Table 63. Middle East & Africa Major Depressive Disorder (MDD) Market Size by Country (2022-2027) & (US$ Million) Table 64. Pfizer Company Details Table 65. Pfizer Business Overview Table 66. Pfizer Major Depressive Disorder (MDD) Product Table 67. Pfizer Revenue in Major Depressive Disorder (MDD) Business (2016-2021) & (US$ Million) Table 68. Pfizer Recent Development Table 69. GlaxoSmithKline Company Details Table 70. GlaxoSmithKline Business Overview Table 71. GlaxoSmithKline Major Depressive Disorder (MDD) Product Table 72. GlaxoSmithKline Revenue in Major Depressive Disorder (MDD) Business (2016-2021) & (US$ Million) Table 73. GlaxoSmithKline Recent Development Table 74. Merck Company Details Table 75. Merck Business Overview Table 76. Merck Major Depressive Disorder (MDD) Product Table 77. Merck Revenue in Major Depressive Disorder (MDD) Business (2016-2021) & (US$ Million) Table 78. Merck Recent Development Table 79. AstraZeneca Company Details Table 80. AstraZeneca Business Overview Table 81. AstraZeneca Major Depressive Disorder (MDD) Product Table 82. AstraZeneca Revenue in Major Depressive Disorder (MDD) Business (2016-2021) & (US$ Million) Table 83. AstraZeneca Recent Development Table 84. Eli Lily Company Details Table 85. Eli Lily Business Overview Table 86. Eli Lily Major Depressive Disorder (MDD) Product Table 87. Eli Lily Revenue in Major Depressive Disorder (MDD) Business (2016-2021) & (US$ Million) Table 88. Eli Lily Recent Development Table 89. Johnson & Johnson Company Details Table 90. Johnson & Johnson Business Overview Table 91. Johnson & Johnson Major Depressive Disorder (MDD) Product Table 92. Johnson & Johnson Revenue in Major Depressive Disorder (MDD) Business (2016-2021) & (US$ Million) Table 93. Johnson & Johnson Recent Development Table 94. Forest Laboratories Company Details Table 95. Forest Laboratories Business Overview Table 96. Forest Laboratories Major Depressive Disorder (MDD) Product Table 97. Forest Laboratories Revenue in Major Depressive Disorder (MDD) Business (2016-2021) & (US$ Million) Table 98. Forest Laboratories Recent Development Table 99. Sanofi-Aventis Company Details Table 100. Sanofi-Aventis Business Overview Table 101. Sanofi-Aventis Revenue in Major Depressive Disorder (MDD) Business (2016-2021) & (US$ Million) Table 102. Sanofi-Aventis Recent Development Table 103. H. Lundbeck Company Details Table 104. H. Lundbeck Business Overview Table 105. H. Lundbeck Major Depressive Disorder (MDD) Product Table 106. H. Lundbeck Revenue in Major Depressive Disorder (MDD) Business (2016-2021) & (US$ Million) Table 107. H. Lundbeck Recent Development Table 108. Bristol-Myers Squibb Company Details Table 109. Bristol-Myers Squibb Business Overview Table 110. Bristol-Myers Squibb Major Depressive Disorder (MDD) Product Table 111. Bristol-Myers Squibb Revenue in Major Depressive Disorder (MDD) Business (2016-2021) & (US$ Million) Table 112. Bristol-Myers Squibb Recent Development Table 113. Research Programs/Design for This Report Table 114. Key Data Information from Secondary Sources Table 115. Key Data Information from Primary Sources List of Figures Figure 1. Global Major Depressive Disorder (MDD) Market Share by Type: 2020 VS 2027 Figure 2. Antidepressant Drugs Features Figure 3. SSRIs Features Figure 4. SNRIs Features Figure 5. Benzodiazepines Features Figure 6. Others Features Figure 7. Global Major Depressive Disorder (MDD) Market Share by Application: 2020 VS 2027 Figure 8. Hospitals Case Studies Figure 9. Clinics Case Studies Figure 10. Others Case Studies Figure 11. Major Depressive Disorder (MDD) Report Years Considered Figure 12. Global Major Depressive Disorder (MDD) Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 13. Global Major Depressive Disorder (MDD) Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Major Depressive Disorder (MDD) Market Share by Regions: 2020 VS 2027 Figure 15. Global Major Depressive Disorder (MDD) Market Share by Regions (2022-2027) Figure 16. Global Major Depressive Disorder (MDD) Market Share by Players in 2020 Figure 17. Global Top Major Depressive Disorder (MDD) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Major Depressive Disorder (MDD) as of 2020 Figure 18. The Top 10 and 5 Players Market Share by Major Depressive Disorder (MDD) Revenue in 2020 Figure 19. Global Major Depressive Disorder (MDD) Revenue Market Share by Type (2016-2021) Figure 20. Global Major Depressive Disorder (MDD) Revenue Market Share by Type (2022-2027) Figure 21. North America Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. North America Major Depressive Disorder (MDD) Market Share by Type (2016-2027) Figure 23. North America Major Depressive Disorder (MDD) Market Share by Application (2016-2027) Figure 24. North America Major Depressive Disorder (MDD) Market Share by Country (2016-2027) Figure 25. United States Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Canada Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Major Depressive Disorder (MDD) Market Share by Type (2016-2027) Figure 29. Europe Major Depressive Disorder (MDD) Market Share by Application (2016-2027) Figure 30. Europe Major Depressive Disorder (MDD) Market Share by Country (2016-2027) Figure 31. Germany Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. France Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. U.K. Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Italy Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Russia Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Nordic Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Major Depressive Disorder (MDD) Market Share by Type (2016-2027) Figure 39. Asia-Pacific Major Depressive Disorder (MDD) Market Share by Application (2016-2027) Figure 40. Asia-Pacific Major Depressive Disorder (MDD) Market Share by Region (2016-2027) Figure 41. China Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Japan Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. South Korea Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Southeast Asia Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. India Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Australia Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Major Depressive Disorder (MDD) Market Share by Type (2016-2027) Figure 49. Latin America Major Depressive Disorder (MDD) Market Share by Application (2016-2027) Figure 50. Latin America Major Depressive Disorder (MDD) Market Share by Country (2016-2027) Figure 51. Mexico Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Brazil Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Major Depressive Disorder (MDD) Market Share by Type (2016-2027) Figure 55. Middle East & Africa Major Depressive Disorder (MDD) Market Share by Application (2016-2027) Figure 56. Middle East & Africa Major Depressive Disorder (MDD) Market Share by Country (2016-2027) Figure 57. Turkey Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Saudi Arabia Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. UAE Major Depressive Disorder (MDD) Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Pfizer Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2016-2021) Figure 61. GlaxoSmithKline Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2016-2021) Figure 62. Merck Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2016-2021) Figure 63. AstraZeneca Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2016-2021) Figure 64. Eli Lily Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2016-2021) Figure 65. Johnson & Johnson Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2016-2021) Figure 66. Forest Laboratories Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2016-2021) Figure 67. Sanofi-Aventis Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2016-2021) Figure 68. H. Lundbeck Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2016-2021) Figure 69. Bristol-Myers Squibb Revenue Growth Rate in Major Depressive Disorder (MDD) Business (2016-2021) Figure 70. Bottom-up and Top-down Approaches for This Report Figure 71. Data Triangulation Figure 72. Key Executives Interviewed

Pfizer GlaxoSmithKline Merck AstraZeneca Eli Lily Johnson & Johnson Forest Laboratories Sanofi-Aventis H. Lundbeck Bristol-Myers Squibb